Close
John Glasser

Mathematical Epidemiologist

Education

Affiliations

Projects

Papers

Feng Z, Glasser JW, Hill AN. (2020). On the benefits of flattening the curve: A perspective. Mathematical biosciences, (326)

Feng Z, Feng Y, Glasser JW. (2020). Influence of demographically-realistic mortality schedules on vaccination strategies in age-structured models. Theoretical population biology, (132)

Carlsson RM, Childs LM, Feng Z, Glasser JW, Heffernan JM, Li J, Röst G. (2020). Modeling the waning and boosting of immunity from infection or vaccination. Journal of theoretical biology

Hao L, Glasser JW, Su Q, Ma C, Feng Z, Yin Z, Goodson JL, Wen N, Fan C, Yang H, Rodewald LE, Feng Z, Wang H. (2019). Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study. International journal of epidemiology, 48(4)

Hao L, Glasser JW, Su Q, Ma C, Feng Z, Yin Z, Goodson JL, Wen N, Fan C, Yang H, Rodewald LE, Feng Z, Wang H. (2019). Evaluating vaccination policies to accelerate measles elimination in China: a meta-population modelling study. International journal of epidemiology, 48(4)

Poghotanyan G, Feng Z, Glasser JW, Hill AN. (2018). Constrained minimization problems for the reproduction number in meta-population models. Journal of mathematical biology, 77(6-7)

Huang WT, Chen RT, Hsu YC, Glasser JW, Rhodes PH. (2017). Vaccination and unexplained sudden death risk in Taiwanese infants. Pharmacoepidemiology and drug safety, 26(1)

Feng Z, Hill AN, Curns AT, Glasser JW. (2017). Evaluating targeted interventions via meta-population models with multi-level mixing. Mathematical biosciences, (287)

Glasser JW, Feng Z, Omer SB, Smith PJ, Rodewald LE. (2016). The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study. The Lancet. Infectious diseases, 16(5)

Steele MK, Remais JV, Gambhir M, Glasser JW, Handel A, Parashar UD, Lopman BA. (2016). Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options. Epidemics, (17)

Feng Z, Zheng Y, Hernandez-Ceron N, Zhao H, Glasser JW, Hill AN. (2016). Mathematical models of Ebola-Consequences of underlying assumptions. Mathematical biosciences, (277)

Feng Z, Han Q, Qiu Z, Hill AN, Glasser JW. (2016). COMPUTATION OF ℛ IN AGE-STRUCTURED EPIDEMIOLOGICAL MODELS WITH MATERNAL AND TEMPORARY IMMUNITY. Discrete and continuous dynamical systems. Series B, 21(2)

Fung IC, Gambhir M, Glasser JW, Gao H, Washington ML, Uzicanin A, Meltzer MI. (2015). Modeling the effect of school closures in a pandemic scenario: exploring two different contact matrices. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (60 Suppl 1)

Feng Z, Hill AN, Smith PJ, Glasser JW. (2015). An elaboration of theory about preventing outbreaks in homogeneous populations to include heterogeneity or preferential mixing. Journal of theoretical biology, (386)

Alvey C, Feng Z, Glasser J. (2015). A model for the coupled disease dynamics of HIV and HSV-2 with mixing among and between genders. Mathematical biosciences, (265)

Feng Z, Glasser JW, Hill AN, Franko MA, Carlsson RM, Hallander H, Tüll P, Olin P. (2014). Modeling rates of infection with transient maternal antibodies and waning active immunity: application to Bordetella pertussis in Sweden. Journal of theoretical biology, (356)

Feng Z, Qiu Z, Sang Z, Lorenzo C, Glasser J. (2013). Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy. Mathematical biosciences, 245(2)

Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, Kang G, Parashar UD. (2012). Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PloS one, 7(8)

Foster SO, Hughes K, Tarantola D, Glasser JW. (2011). Smallpox eradication in Bangladesh, 1972-1976. Vaccine, (29 Suppl 4)

Hankins CA, Glasser JW, Chen RT. (2011). Modeling the impact of RV144-like vaccines on HIV transmission. Vaccine, 29(36)

Glasser JW, Hupert N, McCauley MM, Hatchett R. (2011). Modeling and public health emergency responses: lessons from SARS. Epidemics, 3(1)

Glasser J, Feng Z, Moylan A, Del Valle S, Castillo-Chavez C. (2012). Mixing in age-structured population models of infectious diseases. Mathematical biosciences, 235(1)

Glasser J, Taneri D, Feng Z, Chuang JH, Tüll P, Thompson W, Mason McCauley M, Alexander J. (2010). Evaluation of targeted influenza vaccination strategies via population modeling. PloS one, 5(9)

Feng Z, Yang Y, Xu D, Zhang P, McCauley MM, Glasser JW. (2009). Timely identification of optimal control strategies for emerging infectious diseases. Journal of theoretical biology, 259(1)

Pitzer VE, Viboud C, Simonsen L, Steiner C, Panozzo CA, Alonso WJ, Miller MA, Glass RI, Glasser JW, Parashar UD, Grenfell BT. (2009). Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (New York, N.Y.), 325(5938)

Curns AT, Coffin F, Glasser JW, Glass RI, Parashar UD. (2009). Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015. The Journal of infectious diseases, (200 Suppl 1)

Barskey AE, Glasser JW, LeBaron CW. (2009). Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine, 27(44)

Glasser JW, Foster SO, Millar JD, Lane JM. (2008). Evaluating public health responses to reintroduced smallpox via dynamic, socially structured, and spatially distributed metapopulation models. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (46 Suppl 3)

Kennedy A, Glasser J, Covello V, Gust D. (2008). Development of vaccine risk communication messages using risk comparisons and mathematical modeling. Journal of health communication, 13(8)

Dayan GH, Iskander J, Glasser J, English-Bullard R, Fullerton KE, Chen R. (2005). Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS). Pharmacoepidemiology and drug safety, 14(10)

Best JM, Castillo-Solorzano C, Spika JS, Icenogle J, Glasser JW, Gay NJ, Andrus J, Arvin AM. (2005). Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004. The Journal of infectious diseases, 192(11)

Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE. (2004). Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38(12)

Glasser J, Meltzer M, Levin B. (2004). Mathematical modeling and public policy: responding to health crises. Emerging infectious diseases, 10(11)

If you’d like to update your profile, please email modifications to questions@midasnetwork.us.